# Argenx to Buy Forte Biosciences for $2.2 Billion

> **Newsylist Open Intelligence Dossier** · First detected: 2026-07-27 15:29 UTC · Category: Business · Sources: 8 · Current Velocity: 5.66

## Executive Summary
8 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

## Intelligence Brief
"Argenx to Buy Forte Biosciences for $2.2 Billion" is generating significant coverage in the Business category, with 8 articles from 8 distinct sources tracked by Newsylist so far.


Outlets currently covering the story include Yahoo Finance, STAT, Axios and GlobeNewswire. Newsylist measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### Why is "Argenx to Buy Forte Biosciences for $2.2 Billion" trending?
Because 8 independent news sources published 8 articles about it in a short window — a coverage burst Newsylist classifies as a trend.

### How does Newsylist measure this trend?
Newsylist scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.

### Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.

## Key People, Organizations & Locations
Billion, Argenx, Buy Forte Biosciences, Acquire Forte Biosciences Inc Adding First-in-Class, Antibody FB102, Immunology Pipeline, Forte Bio, Forte Biosciences, Acquire Forte Biosciences Inc Adding First-in-Class Anti-CD122 Antibody FB102, Its Immunology Pipeline

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Yahoo Finance | argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline | 2026-07-27 10:42 | [Source Link](https://news.google.com/rss/articles/CBMingFBVV95cUxOVE1zNmVMTHI2cUtXZndrejRHVFAzQURwSVJteXZHX0E4RVpUQ2RIYXJicHM4aUFwam9LQlVYT01ocDRaR1o3M2ZkUU1JRjNia0FfNUNxWjN3Q3NnMHV5eUdzaFRWOUdJSlRQMktybmxHWnhjcmRhNGdFUHRueUF6bXJtTGRwUnVrN1RXanNJUlNSUEZrX1R5TlUxaGlVdw?oc=5) |
| STAT | Argenx to buy autoimmune-focused Forte Biosciences for $2.2B | 2026-07-27 05:29 | [Source Link](https://news.google.com/rss/articles/CBMikwFBVV95cUxOZkJJaVhENXM4NUdLYWVYTWx6RVpOS09yNXlfR0t3NzlXZUo3aVlfZnJjQjBCQmNwZ0ROR2xDVk5LcHQ3VFdLOFVQUjZCMEw5NkdkNEhibmg1UC1NbUN0T1BoRnN4bE5xR3VHVnlJTGRxVmVJWktmUlZuNWx5bDBZZk9POHJXWUNZck9na3N4SXRDTlE?oc=5) |
| Axios | Argenx to acquire Forte Biosciences for $2.2B | 2026-07-27 05:29 | [Source Link](https://news.google.com/rss/articles/CBMijwFBVV95cUxPSG04NE9yLUpoc1lsWmxfU0tFVjdUQUpUZHlqVE9sZkZjbkNIY01QUk1VcWZfR1FJMWhoRUFJWkZOa3ZZUEh4cWZ5QkhERWRpckp5QjNHaUplek14YTVoVGVSejNsalVLVXExYmtOT01wWjlweFZuVjRjQ1RXSFJwbGg2ZWJiVk9PbW9vSXFMOA?oc=5) |
| GlobeNewswire | argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline | 2026-07-27 05:29 | [Source Link](https://news.google.com/rss/articles/CBMilAJBVV95cUxOc3Fqc3hYU1lYWlRpR2l1N3YzM2FsakhySGQ4ek4wcW1ITUt5MEVDUVVuOUVqLXlGckt0ZTBhakgxdkNxUUk2VGxXUm5RWUU1WDJBOVh2X1Fqb2MyMklwVU1sR2EzeGJiT3JEc2NVbDB5d1hGanRZWVUxbXhSNjJRcXdOdDA3MUFfcS1iVTRUNDFEX0FyVk05YXVXbEllSTV4SUo4d0NiTEh2RUFIcGJZUldZdnk5Q1NYWS1QeHpOUEJrTFVFa0FvekRvdk1CN28yaE92ZTBMbkpRSURuRFJ4Q1E2cFlIVVpIYTFYNTVUU2x5b2RlOW9qVHlmSEN0OGh3eHcxcDRMQ3F4UzVWakg3dnZOOXQ?oc=5) |
| FirstWord Pharma | argenx to buy Forte Bio for $2.2B in immunology push | 2026-07-27 05:29 | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTFBmMTJmTEhGeUJPQ0tmR05oRGZkNERzNVdfWmJXMTNfZ25OdU5rclJoSUdiZ2ZzdEVXbkZYaW1ia3hOT0dlTks3SnFVWVpZNFRub0hF?oc=5) |
| Endpoints News | Argenx to pick up autoimmune biotech Forte Biosciences for $2.2B | 2026-07-27 05:29 | [Source Link](https://news.google.com/rss/articles/CBMikAFBVV95cUxPbGJQQ2xoZWdsYUFBY0ZfQXI1eEgwY0J5c241bF9ac21KdjBWeV8xem9rQ25pLXJnX2lDQjlzeDhiT0xrYXhXRkJxYmR6QnkwLUloUnBYb3Nzam01V0JRY19PWG9sY2tqaUNBMnhPWTgwR2NFQ3F0NC1aaVB4aG1RYnk4Y0JFWjg2eC12Q3RYcHM?oc=5) |
| Fierce Biotech | Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drug | 2026-07-27 05:29 | [Source Link](https://news.google.com/rss/articles/CBMiowFBVV95cUxPay1YdGdFTkNIN1RzQ1h6YWQ4bWU4NUVsVWxvYUV1RnpNLTZ2c29aSTVxRjV1SXBXYnVHajF5UHBwREVjakFvbVh2dklYSVJxZTFVc2l1dlZUa3VQMkR6Wk03dmZKZ2xiVVFqQnh5NzlTMkdKX21LS3h5ejNmVEoxYXgzYm5IcXhRekxKbFBqSTVha3QwZnVXcTJ3ZkpfSWo3dXBN?oc=5) |
| WSJ | Argenx to Buy Forte Biosciences for $2.2 Billion | 2026-07-27 05:29 | [Source Link](https://news.google.com/rss/articles/CBMikwFBVV95cUxQOUdEMW9fWFd2dnh0Ti1rc1NJNUpnMDdWQ3dhT2lBbUR4RDhLVVZiQ1dXVGRiaXMwckg2S240MTNDS0tIc0JxUEZZa3JJeEZXTGFxS0ZPMjFwMjNUUnFCY29HNHdhSHF5dzhULUhQRGgxSC1IVExRay1aTFE0MERQMDQ1VlgxMXk3Z1FXaHhhWDlDa3c?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-07-27/argenx-to-buy-forte-biosciences-for-2-2-billion*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*